Inventor
TODARO GEORGE J
US24 patents
⚠️ This page may combine multiple inventors who share the name “TODARO GEORGE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONCOGEN
12 patentsUS4645828AFeb 24, 1987
Platelet related growth regulator
ONCOGEN33 citations92
US5248666ASep 28, 1993
Methods for inhibiting neoplastic cell proliferation using platelet factor 4
ONCOGEN18 citations82
US4737580AApr 12, 1988
Platelet related growth regulator
ONCOGEN18 citations82
US4774318ASep 27, 1988
Snake venom growth arresting peptide
ONCOGEN15 citations74
US4731439AMar 15, 1988
Snake venom growth arresting peptide
ONCOGEN8 citations74
US4714683ADec 22, 1987
Polypeptide tumor inhibitors and antibodies thereto
ONCOGEN9 citations74
US4590003AMay 20, 1986
Platelet related growth regulator
ONCOGEN17 citations74
US5077312ADec 31, 1991
Biologically active lipids binding membrane receptors
ONCOGEN7 citations73
US5011777AApr 30, 1991
Vectors encoding brain derivable polypeptide factors
ONCOGEN6 citations63
US4963485AOct 16, 1990
Brain derivable polypeptide factors and antibodies thereto
ONCOGEN3 citations63
US5093045AMar 3, 1992
Biologically active lipids binding membrane receptors
ONCOGEN4 citations62
US4990289AFeb 5, 1991
Biologically active lipids binding membrane receptors
ONCOGEN1 citations52
TODARO GEORGE J
5 patentsUS5240912AAug 31, 1993
Transforming growth factor (TGF) peptides
TODARO GEORGE J64 citations95
US4816561AMar 28, 1989
Biologically active polypeptides
TODARO GEORGE J59 citations95
US4863899ASep 5, 1989
Biologically active polypeptides
TODARO GEORGE J47 citations92
US12247069B2Mar 11, 2025
Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disorders
TODARO GEORGE J0 citations62
US11279753B2Mar 22, 2022
Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disorders
TODARO GEORGE J0 citations62